We have been conducting researches on FPP on the theme of "Healthy Aging", aimed at achieving to reduce medical costs though preventive medicine.

From June 26 to 27, 2017, The 17th PARIS REDOX was held in France, where Prof. Rachmilewitz, senior director of Osato Research Institute, made a FPP presentation.

Prof. Rachmilewitz presented that FPP was found to decrease oxidative stress both in-vivo and in-vitro in congenital and acquired hemolytic anemias. He finished the presentation by stating that it is possible that longer treatment duration and/or a combination with iron chelators will yield better results.